Do Medicare Beneficiaries Living With HIV/AIDS Choose Prescription Drug Plans That Minimize Their Total Spending?
نویسندگان
چکیده
This article examines whether California Medicare beneficiaries with HIV/AIDS choose Part D prescription drug plans that minimize their expenses. Among beneficiaries without low-income supplementation, we estimate the excess cost, and the insurance policy and beneficiary characteristics responsible, when the lowest cost plan is not chosen. We use a cost calculator developed for this study, and 2010 drug use data on 1453 California Medicare beneficiaries with HIV who were taking antiretroviral medications. Excess spending is defined as the difference between projected total spending (premium and cost sharing) for the beneficiary's current drug regimen in own plan vs spending for the lowest cost alternative plan. Regression analyses related this excess spending to individual and plan characteristics. We find that beneficiaries pay more for Medicare Part D plans with gap coverage and no deductible. Higher premiums for more extensive coverage exceeded savings in deductible and copayment/coinsurance costs. We conclude that many beneficiaries pay for plan features whose costs exceed their benefits.
منابع مشابه
2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.
BACKGROUND Effective January 1, 2006 Medicare Part D became a new source of prescription drug coverage for people with HIV/AIDS in the United States. The implementation of Part D has affected access to antiretrovirals for people with HIV/AIDS. In North Carolina, access can be difficult because of the state's struggling safety net programs and the growing HIV-infected populations among Blacks an...
متن کاملMedicare spending on HMOs and stand-alone drug plans: what is it worth to beneficiaries?
(1) Medicare beneficiaries value the expansion of stand-alone prescription drug plans more than they value the expansion of HMOs. (2) The addition of subsidized stand-alone prescription drug plans generates nine times as much value per government dollar as the increase in payments to HMOs.
متن کاملA Medicare prescription drug benefit: focusing on coverage and cost.
Introduction P harmaceuticals are a critical element of modern medical treatment, yet the traditional Medicare benefits package does not include coverage of outpatient prescription drugs. This omission is significant because the 38.1 million people who comprise the Medicare population are disproportionately likely to use drugs.The elderly represent 14 percent of the U.S. population but account ...
متن کاملEnsuring Access to Affordable Drug Coverage in Medicare
The long-awaited outpatient prescription drug benefit in Medicare began January 2006. Despite its importance, the drug benefit is controversial. Instead of paying directly for prescriptions, the program will operate through competing private plans. Although it is too early to assess the full impact of Part D on beneficiaries, health plans and providers, employers, and taxpayers, we can discuss ...
متن کاملDrug coverage for Medicare beneficiaries: why protection may be in jeopardy.
F ollowing a period of growth over the last decade, trends suggest that Medicare beneficiaries access to affordable prescription drug benefits has begun to decline. Since the late 1990s, the engines that had been driving that growthemployer health plans and Medicare HMOshave been offering increasingly less generous benefits to fewer people.There is no evidence that the private market or curr...
متن کامل